1. Home
  2. TSHA vs AVO Comparison

TSHA vs AVO Comparison

Compare TSHA & AVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSHA
  • AVO
  • Stock Information
  • Founded
  • TSHA 2019
  • AVO 1983
  • Country
  • TSHA United States
  • AVO United States
  • Employees
  • TSHA N/A
  • AVO N/A
  • Industry
  • TSHA Biotechnology: Pharmaceutical Preparations
  • AVO Farming/Seeds/Milling
  • Sector
  • TSHA Health Care
  • AVO Consumer Staples
  • Exchange
  • TSHA Nasdaq
  • AVO Nasdaq
  • Market Cap
  • TSHA 728.4M
  • AVO 836.8M
  • IPO Year
  • TSHA 2020
  • AVO 2020
  • Fundamental
  • Price
  • TSHA $2.65
  • AVO $12.05
  • Analyst Decision
  • TSHA Strong Buy
  • AVO Strong Buy
  • Analyst Count
  • TSHA 6
  • AVO 2
  • Target Price
  • TSHA $8.17
  • AVO $15.50
  • AVG Volume (30 Days)
  • TSHA 2.6M
  • AVO 282.6K
  • Earning Date
  • TSHA 08-11-2025
  • AVO 09-08-2025
  • Dividend Yield
  • TSHA N/A
  • AVO N/A
  • EPS Growth
  • TSHA N/A
  • AVO 108.17
  • EPS
  • TSHA N/A
  • AVO 0.52
  • Revenue
  • TSHA $7,224,000.00
  • AVO $1,392,900,000.00
  • Revenue This Year
  • TSHA N/A
  • AVO $8.85
  • Revenue Next Year
  • TSHA N/A
  • AVO N/A
  • P/E Ratio
  • TSHA N/A
  • AVO $23.34
  • Revenue Growth
  • TSHA N/A
  • AVO 29.50
  • 52 Week Low
  • TSHA $1.05
  • AVO $9.56
  • 52 Week High
  • TSHA $3.31
  • AVO $15.25
  • Technical
  • Relative Strength Index (RSI)
  • TSHA 56.06
  • AVO 51.84
  • Support Level
  • TSHA $2.34
  • AVO $12.00
  • Resistance Level
  • TSHA $2.81
  • AVO $12.45
  • Average True Range (ATR)
  • TSHA 0.16
  • AVO 0.29
  • MACD
  • TSHA 0.01
  • AVO -0.03
  • Stochastic Oscillator
  • TSHA 67.37
  • AVO 38.93

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

About AVO Mission Produce Inc.

Mission Produce Inc is engaged in the business of producing and distributing avocados, serving retail, wholesale, and food service customers. Also, the company provides additional services like ripening, bagging, custom packing, and logistical management. The company's operating segments include Marketing and Distribution, International Farming and Blueberries. It generates maximum revenue from the Marketing and Distribution segment. The Marketing and Distribution segment sources fruit mainly from growers and then distributes fruit through a distribution network. Geographically distributed across North America, China, Europe, and the U.K.

Share on Social Networks: